Safety Study of 2DG With Stereotactic Radiosurgery
NCT00247403
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Pharmaceutical company no longer manufactures drug
Conditions
Intracranial Neoplasms
Neoplasm Metastasis
Interventions
DRUG:
2-deoxyglucose (2DG)
Sponsor
University of Iowa